Trial intelligence / Profile preview

Dapsone Gel in Females With Skin of Color and Acne Vulgaris

NCT02032407Phase 4Completed

Sponsor
Allergan
Start
Dec 2013
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dapsone in acne vulgaris, sponsored by Allergan. Started Dec 2013; status: completed.

02

Drugs

dapsone
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT02032407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02032407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call